Figure 4.
Docking between (A) wild‐type (WT)‐RBD (B) Omicron BA.1‐RBD, and (C) Omicron BA.1.1‐RBD (D) Omicron BA.2‐RBD (E) Omicron BA.3‐RBD with hACE2. Based on docking energy it shows Omicron BA.2 and BA.3‐RBD have a high binding affinity with hACE2 compared to Omicron variant BA.1, B.1.1, and WT. Docking scores are shown in MM/GBSA free energy decomposition analysis for binding free energy calculations at the top of each variant. hACE2, human angiotensin I‐converting enzyme 2; RBD, receptor‐binding domain.